Sperm DNA fragmentation: when to test

The semen analysis measures the number, motility and morphology of sperm, but it does not “see” the integrity of their genetic material. Sperm DNA fragmentation testing aims to fill precisely this gap, by measuring the proportion of sperm with broken DNA strands.

This test has become popular, yet it is often offered without a clear indication. The question is not whether it sounds sophisticated, but whether its result actually changes decisions and the final outcome for a particular couple.

What is sperm DNA fragmentation?

Inside the head of each sperm lies the paternal genetic material, packaged very tightly. When the strands of this DNA carry breaks, we speak of fragmentation. The result is usually expressed as a DNA fragmentation index (DFI), that is, the proportion of sperm with damage.

Such damage can arise from oxidative stress, inflammation, varicocele, smoking, obesity, high fever or advancing age. A high proportion does not necessarily mean an inability to father a child, because the egg has repair mechanisms of its own.

How is it measured?

Several laboratory methods are used — the best known are SCSA, TUNEL, the Comet assay and the sperm chromatin dispersion (SCD) test. Each measures the damage differently and yields different reference limits.

This is the major practical problem: there is no single, universally accepted “gold-standard” method nor one unified threshold. A value around 25–30% is often cited as a cut-off, but it varies by method and by laboratory, so results are not always directly comparable.

Is it a routine test?

No. International guidelines do not recommend DNA fragmentation testing as a routine part of the initial work-up of every infertile couple. Its clinical utility remains limited and uncertain, mainly because the evidence on whether it changes the live-birth rate is weak.

In other words, a “good” or “bad” value is rarely enough on its own to determine treatment. That is why the test should not be requested indiscriminately.

So when might it have value?

The test may be considered in specific settings: recurrent pregnancy loss (repeated miscarriages), repeated implantation failure after IVF, and couples with unexplained infertility. In these situations the information can sometimes help with decision-making.

The more recent European Association of Urology (EAU) guidelines tend to suggest testing in couples with recurrent pregnancy loss or unexplained infertility, whereas the AUA/ASRM guidelines keep it out of the initial, routine work-up. The indication should always be targeted.

If the result is high, what then?

First, reversible causes are sought and corrected: stopping smoking, weight loss, treating inflammation or infection, surgical repair of a clinically significant varicocele, and avoiding excess heat. Because sperm production takes about three months, improvements need time.

Antioxidant supplements are often mentioned, but the evidence that they increase births is weak. In some cases of severe fragmentation, IVF with intracytoplasmic sperm injection (ICSI) — possibly using testicular sperm — may be discussed, although the data here are also limited.

What is the key message?

DNA fragmentation is an interesting test, but it is neither a panacea nor a mandatory step for every man. It has a role in selected scenarios and when the result can genuinely change management.

Before having the test, it is worth asking your doctor: “If it comes back high or low, what will change in my treatment?” If the answer is “nothing”, then the test is probably not needed.

Summary

Sperm DNA fragmentation testing measures damage to the genetic material of sperm, but it is not a routine test: its clinical utility is limited and there is no single method or threshold. It may be considered in selected cases — recurrent pregnancy loss, repeated implantation failure, unexplained infertility. When a high value is found, correcting reversible causes takes priority. Before the test, the crucial question is whether the result will genuinely change treatment.

⚕ Medically reviewed by Prof. Stratis Kolibianakis · Thessaloniki Medical Association Reg. No. 16340

ARTICLE 10 · MALE INFERTILITY